Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antagonist Protocol in IVF Patients
NCT02335736Phase 2Unknown
- Sponsor
- Woman's Health University Hospital
- Start
- Jan 2015
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetrorelix in infertility (3 arms), sponsored by Woman's Health University Hospital. Primary endpoint: Number of oocytes collected and fertilized at 6 months. Status: unknown.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02335736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335736.